Boston Scientific Corporation BSX
44.34 USD +0.14 (+0.32%)
At closeNov 13, 2026, 7:26 PM EST
44.11 -0.23 -0.52%
After hours · Nov 13, 7:26 PM ET
44.08 Day range 44.69
41.58 52-week range 104.98
- YTD
- -53.50%
- 1 year
- -57.76%
News
zacks.com Bear of the Day: Boston Scientific (BSX) I last wrote about Boston Scientific ( BSX ) as the Bear of the Day in early August after their Q2 report and management's lowered guidance propelled analysts to notch down their EPS estimates for…
defenseworld.net 72,575 Boston Scientific Corporation $BSX Shares Sold by Allspring Global Investments Holdings LLC Allspring Global Investments Holdings LLC cut its position in shares of Boston Scientific Corporation (NYSE: BSX) by 11.4% in the undefined quarter, according to its most recent disclosure with the…
zacks.com Boston Scientific Bets on WATCHMAN Growth Despite Market Slowdown BSX bets on WATCHMAN growth through clinical trials and physician outreach, even as slowing demand and rising competition cloud its outlook.
prnewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such…
defenseworld.net AMG National Trust Bank Acquires 34,303 Shares of Boston Scientific Corporation $BSX AMG National Trust Bank bought a new stake in shares of Boston Scientific Corporation (NYSE: BSX) during the undefined quarter, according to its most recent 13F filing with the Securities and…
seekingalpha.com Boston Scientific Corporation (BSX) Presents at Stifel 2026 Healthcare Conference 2026 Transcript Boston Scientific Corporation (BSX) Presents at Stifel 2026 Healthcare Conference 2026 Transcript
marketbeat.com Boston Scientific Targets Long-Term Growth as Key Businesses Face Pressure Through 2027 Boston Scientific NYSE: BSX executives said they expect durable growth across the company's interventional portfolio, while acknowledging that its pulsed field ablation and WATCHMAN businesses face…
investorplace.com Insider Buying Signals: 3 Healthcare Stocks to Watch Insider buying and share buybacks have put Prothena, Rapport Therapeutics and Azenta on the radar. See the catalysts and risks behind each stock.
globenewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX). Such…
zacks.com Wall Street Analysts Look Bullish on Boston Scientific (BSX): Should You Buy? Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm…
defenseworld.net Boston Scientific Corporation $BSX Stock Bought by Ethic Inc. Ethic Inc. boosted its position in Boston Scientific Corporation (NYSE: BSX) by 11.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange…
benzinga.com Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.84% on an annualized basis producing an average annual return of 14.73%. Currently, Boston Scientific has a market…
benzinga.com TD Cowen Downgrades Boston Scientific to Hold, Lowers Price Target to $46 TD Cowen analyst Joshua Jennings downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $56 to $46.
benzinga.com Barclays Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $45 Barclays analyst Christopher Pasquale maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $48 to $45.- benzinga.com Jefferies Downgrades Boston Scientific to Hold, Lowers Price Target to $46 Jefferies analyst Matthew Taylor downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $60 to $46.
- benzinga.com Canaccord Genuity Maintains Buy on Boston Scientific, Lowers Price Target to $48 Canaccord Genuity analyst William Plovanic maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $66 to $48.
benzinga.com RBC Capital Maintains Outperform on Boston Scientific, Lowers Price Target to $52 RBC Capital analyst Kendall Au maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $70 to $52.- benzinga.com Citigroup Maintains Neutral on Boston Scientific, Lowers Price Target to $44 Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Neutral and lowers the price target from $48 to $44.
- benzinga.com Leerink Partners Maintains Outperform on Boston Scientific, Lowers Price Target to $50 Leerink Partners analyst Mike Kratky maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $55 to $50.
benzinga.com UBS Maintains Buy on Boston Scientific, Lowers Price Target to $57 UBS analyst Patrick Wood maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $67 to $57.
benzinga.com Wells Fargo Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $45 Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $48 to $45.
benzinga.com These Analysts Revise Their Forecasts On Boston Scientific After Q3 Results Boston Scientific beat Q3 estimates but cut FY26 guidance; Q4 forecasts missed expectations. Analysts adjusted price targets.
benzinga.com Baird Maintains Outperform on Boston Scientific, Raises Price Target to $51 Baird analyst David Rescott maintains Boston Scientific (NYSE:BSX) with a Outperform and raises the price target from $50 to $51.- benzinga.com BTIG Maintains Buy on Boston Scientific, Lowers Price Target to $49 BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $56 to $49.
benzinga.com Needham Maintains Buy on Boston Scientific, Lowers Price Target to $48 Needham analyst Mike Matson maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $57 to $48.
benzinga.com Boston Scientific Overshadowed by Hackers, Headwinds, and Lower Guidance Boston Scientific slips after a cyber fallout offsets a Q3 consensus beat. Management targets a 2027 cycle trough and 2030 expansion.
benzinga.com Boston Scientific Q3 2026 Earnings Call Transcript Boston Scientific (NYSE:BSX) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This content is powered by…- benzinga.com Boston Scientific Lowers FY2026 Adj EPS Guidance from $3.28-$3.32 to $3.16-$3.18 vs $3.23 Est; Lowers FY2026 Sales Guidance from $21.178B-$21.379B to $20.927B vs $21.143B Est Boston Scientific (NYSE:BSX) lowers FY2026 Adj EPS guidance from $3.28-$3.32 to $3.16-$3.18 vs $3.23 analyst estimate. Lowers FY2026 sales outlook from $21.178 billion-$21.379 billion to $20.927…
benzinga.com Boston Scientific Sees Q4 Adj EPS $0.77-$0.79 vs $0.84 Est; Sees Sales $5.127B-$5.233B vs $5.404B Est Boston Scientific (NYSE:BSX) is looking for Q4 Adj EPS of $0.77-$0.79 vs $0.84 analyst estimate. sees sales of $5.127 billion-$5.233 billion vs $5.404 billion analyst estimate.- benzinga.com Boston Scientific Q3 Adj. EPS $0.73 Beats $0.72 Estimate, Sales $5.138B Beat $5.046B Estimate Boston Scientific (NYSE:BSX) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.72 by 1.39 percent. This is a 2.67 percent decrease over earnings of $0.75…
benzinga.com Microsoft, Alphabet On Deck Wednesday As AI Spending, Cloud Growth Face Test Microsoft and Alphabet headline Wednesday’s reports, with investors weighing whether AI infrastructure spending is translating into durable cloud and advertising growth. GE Vernova, Amphenol, Banco…- benzinga.com Stifel Maintains Buy on Boston Scientific, Lowers Price Target to $55 Stifel analyst Rick Wise maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $60 to $55.
- benzinga.com Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $51 Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $57 to $51.
ainvest.com Elkhorn Bets Big on White Mountains, Exits Meta Elkhorn Partners allocated 21.08% of assets to White Mountains Insurance (WTM), displacing prior top holdings in Q3 2026.
ainvest.com Aurora Investment Counsel Boosts Qualys, Exits Beauty Aurora Investment Counsel increased portfolio concentration by boosting top three holdings to 4.31%, exiting three ...
finance.yahoo.com Life Science Cares Boston Outlines Ambitious Plans to Expand Industry Coalition and Support Local Nonprofits Life Science Cares Boston marks 10 years with ambitious plans to expand industry support, strengthen nonprofit partnerships ...
ainvest.com Bollard Group’s Portfolio Collapses 99.9%, Anchored by Boston Scientific Bollard Group's portfolio collapsed 99.9% to $3.32M in Q3 2026 due to massive position reduction, not market declines.
- msn.com Bear of the day: Boston Scientific (BSX) I last wrote about Boston Scientific (BSX) as the Bear of the Day in early August after their Q2 report and management's lowered guidance propelled analysts to notch down their EPS estimates for this…
finance.yahoo.com Is There Any Reason To Invest In Edwards Lifesciences Stock? For questions about this article or underlying research, email help@trefis.com.
- bloomberg.com H&R REIT Holders Nix Sale to Blackstone and GO, Rebuking CEO Shareholders of H&R Real Estate Investment Trust voted against a plan to break up and sell the company to buyers including Blackstone Inc., rejecting a complex deal that would have allowed the CEO’s…
royalgazette.com Butterfield gains 0.75% in New York The Royal Gazette/BSX Index closed unchanged on 3,463.38 today as only shares of Butterfield Bank traded on the Bermuda Stock ...
- msn.com Nationwide ground stop impacts Logan Airport in Boston Flights at Logan Airport in Boston are being impacted by a nationwide ground stop issued by the FAA. WBZ-TV's Kristina Rex reports.
ad-hoc-news.de Boston Scientific stock faces fresh recall and growth scrutiny Boston Scientific stock faced fresh scrutiny after Zacks named it Bear of the Day. Device recalls added to concerns about ...
- msn.com Boston College men's hockey vs. UMass: Live updates, analysis for game 1 of series Can the Eagles get back to their winning ways this weekend? Friday night's matchup in Amherst could provide the spark they are looking for.
- msn.com Boston College announced as venue for some MIAA championship football games Boston College's Alumni Stadium will replace Gillette Stadium as the host of some of the MIAA's high school championship football games this year.
msn.com Browns final injury report: Emmanuel McNeil-Warren gets his chance, Denzel Boston TBD The Cleveland Browns ruled out two players for Week 10 against the Texans, opening the door for rookie Emmanuel McNeil-Warren to step into a starting role.